Clene Inc. (CLNN) vs INmune Bio, Inc. (INMB)
A side-by-side comparison of Clene Inc. and INmune Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLNN
Clene Inc.
$3.98HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
INMB
INmune Bio, Inc.
$1.83HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — CLNN vs INMB
growth of $100 · dividends reinvested · last 8yCLNN -98.0% (-38.8%/yr)INMB -75.7% (-16.2%/yr)INMB compounded faster over this window
Log scale — wide-divergence pair
CLNN INMB
CLNN vs INMB: by the numbers
- •CLNN is the larger company ($51M vs $49M market cap).
- •Both run net losses; CLNN's is the smaller (-20059.90% vs -91866.00% net margin).
Metrics side by side
Valuation
| Metric | CLNN | INMB |
|---|---|---|
| P/S ratio | 258.16 | N/A |
| P/B ratio | N/A | 2.39 |
Profitability
| Metric | CLNN | INMB |
|---|---|---|
| Gross margin | 78.50% | 100.00% |
| Operating margin | -11541.50% | -61738.00% |
| Net margin | -20059.90% | -91866.00% |
| ROE | N/A | -90.44% |
| ROIC | -109.13% | -96.37% |
Growth (annualized)
| Metric | CLNN | INMB |
|---|---|---|
| Revenue CAGR (5Y) | -18.30% | N/A |
| Total return CAGR (5Y) | -51.16% | -36.88% |
Frequently asked
- How have CLNN and INMB total returns compared?
- Over the past 5 years, CLNN delivered -51.16% and INMB delivered -36.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.